Membranous glomerulonephritis in patients with rheumatoid arthritis

A Yoshida1, K Morozumi, A Takeda

  • 1Division of Nephrology, Nagoya Daini Red Cross Hospital, Japan.

Clinical Therapeutics
|November 1, 1994
PubMed

Insights

Rheumatoid arthritis (RA) patients have an increased risk of developing membranous glomerulonephritis (MGN). This kidney condition can occur regardless of whether patients are treated with antirheumatic drugs.

Area of Science:

  • Nephrology
  • Rheumatology
  • Pathology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • Membranous glomerulonephritis (MGN) is a common cause of nephrotic syndrome in adults.

Purpose of the Study:

  • To investigate the association between rheumatoid arthritis and membranous glomerulonephritis.
  • To determine if antirheumatic agents influence the development of MGN in RA patients.

Main Methods:

  • Retrospective analysis of 24 RA patients diagnosed with MGN via renal biopsy.
  • Evaluation of renal biopsy findings (light microscopy, electron microscopy, immunofluorescence).
  • Review of patient laboratory data and medical history, including antirheumatic drug use.

Main Results:

  • All 24 RA patients exhibited renal lesions consistent with idiopathic MGN.
  • Eighteen patients had prior exposure to antirheumatic agents (bucillamine, D-penicillamine, gold).
  • No specific link was established between antirheumatic drug use and MGN development.

Conclusions:

  • Patients with rheumatoid arthritis have a predisposition to develop membranous glomerulonephritis.
  • MGN in RA patients can occur independently of treatment with antirheumatic medications.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...